A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Saved in:
| Title: | A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. |
|---|---|
| Authors: | Scandlyn MJ; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand., Stuart EC, Somers-Edgar TJ, Menzies AR, Rosengren RJ |
| Source: | British journal of cancer [Br J Cancer] 2008 Oct 07; Vol. 99 (7), pp. 1056-63. Date of Electronic Publication: 2008 Sep 16. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
